Inhibition by L-valine and L-norleucine of 3-phenylpyruvate-induced insulin release.
Insulin release induced by 3-phenylpyruvate in isolated rat pancreatic islets was inhibited by L-valine, L-norleucine or aminooxyacetate. The inhibitory effect of these three agents coincided with a lesser stimulation by 3-phenylpyruvate of 14CO2 output from islets prelabelled with L-[U-14C] glutamine. Conversely, 3-phenylpyruvate augmented the rate of conversion of L-valine to 2-ketoisovalerate and that of L-norleucine to 2-ketocaproate. However, 3-phenylpyruvate, which increased 2-ketoisovalerate oxidative decarboxylation, inhibited 14CO2 production by islets exposed to D, L-[1-14C] norleucine. These findings reveal that distinct nutrient secretagogues (e.g. 3-phenylpyruvate and L-norleucine), which are each able to stimulate insulin release, may act antagonistically upon the secretory process when used in combination. The present results also emphasize the relevance of both mitochondrial oxidation and intracellular transfer of reducing equivalents as determinants of the secretory response to such nutrients as 3-phenylpyruvate and norleucine.
D000614:Aminocaproates / Q000494:pharmacology*; D000625:Aminooxyacetic Acid / Q000494:pharmacology; D000818:Animals; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism*; D007700:Kinetics; D007930:Leucine / Q000378:metabolism; D009646:Norleucine / Q000378:metabolism / Q000494:pharmacology*; D010667:Phenylpyruvic Acids / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D051381:Rats; D014633:Valine / Q000378:metabolism / Q000494:pharmacology*
D000614:Aminocaproates; D007328:Insulin; D010667:Phenylpyruvic Acids; D000625:Aminooxyacetic Acid; D009646:Norleucine; D007930:Leucine; D014633:Valine; C031606:phenylpyruvic acid